Table 5.
Anglo-European | SOUTH EAST ASIAN and EAST ASIAN (n = 1397) |
SOUTH ASIAN and MIDDLE EASTERN (n = 2573) |
MĀORI and PASIFIKA (n = 840) |
OTHER (n = 340) |
|
---|---|---|---|---|---|
Metformin Use | 1 | 1.328 (0.939–1.633) | 1.283 (1.033–1.593) | 1.457 (1.131–1.593) | 1.466 (1.007–2.135) |
Short-Acting Insulin Use | 1 | 0.874 (0.743–1.029) | 1.140 (1.003–1.296) | 0.861 (0.808–1.142) | 0.930 (0.723–1.195) |
Long-Acting Insulin Use | 1 | 0.729 (0.614–0.865) | 1.260 (1.108–1.433) | 0.903 (0.759–1.073) | 0.845 (0.655–1.090) |
Emergency Caesarean Section | 1 | 1.118 (0.897–1.393) | 0.960 (0.800–1.151) | 1.218 (0.973–1.525) | 1.603 (1.186–2.168) |
Elective Caesarean Section | 1 | 0.900 (0.734–1.103) | 1.201 (1.029–1.402) | 0.560 (0.443–0.708) | 1.160 (0.868–1.550) |
Spontaneous Normal Vaginal Delivery | 1 | 1.223 (1.057–1.416) | 0.743 (0.659–0.839) | 1.641 (1.391–1.936) | 0.659 (0.518–0.837) |
Perinatal Death | 1 | 0.969 (0.354–2.652) | 1.792 (0.856–3.749) | 0.666 (0.183–2.418) | 0.557 (0.072–4.330) |
NICU Admission | 1 | 0.964 (0.773–1.201) | 0.850 (0.709–1.018) | 1.280 (1.028–1.592) | 1.005 (0.719–1.406) |
Neonatal Hypoglycaemia | 1 | 0.832 (0.698–0.991) | 1.016 (0.885–1.165) | 1.071 (0.893–1.283) | 0.965 (0.740–1.260) |
Congenital Major Abnormalities | 1 | 1.523 (0.742–3.126) | 1.124 (0.598–2.113) | 1.193 (0.529–2.694) | 1.034 (0.302–3.532) |
Congenital Minor Abnormalities | 1 | 1.055 (0.707–1.574) | 0.888 (0.622–1.267) | 0.715 (0.42–1.217) | 1.133 (0.590–2.177) |
Composite Outcomes | 1 | 0.852 (0.726–1.0) | 0.922 (0.811–1.048) | 1.086 (0.917–1.287) | 1.006 (0.787–1.285) |